Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Heart failure and diabetes.

Cornelia Bala1, N Hâncu

  • 1Clinical Center of Diabetes, Nutrition, Metabolic Disease, Cluj-Napoca, Romania. diabet@insin.hearticj.ro

Romanian Journal of Internal Medicine = Revue Roumaine De Medecine Interne
|November 9, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-World Sex Differences in Response to Treatment with Glucagon-like Peptide-1 Receptor Agonists: Analysis of Single-Center Outpatient Case Series.

Medicina (Kaunas, Lithuania)·2025
Same author

Diabetes and Sarcopenia: Metabolomic Signature of Pathogenic Pathways and Targeted Therapies.

International journal of molecular sciences·2025
Same author

Associations of the Social Determinants of Health and Lifestyle Components with Dietary Patterns in a Population of Reproductive Age.

Nutrients·2025
Same author

The Burden of Diabetic Foot Ulcers on Hospital Admissions and Costs in Romania.

Journal of clinical medicine·2025
Same author

Metabolomics in Pathogenic Pathways and Targeted Therapies for Diabetic Neuropathy: A Comprehensive Review.

Metabolites·2025
Same author

The Social Determinants of Health in a Cohort of Romanian Patients with Diabetic and Nondiabetic Neuropathy.

Journal of clinical medicine·2024

Diabetes significantly raises heart failure risk. Management involves standard treatments, avoiding certain diabetes medications, and controlling blood pressure, lipids, and glucose.

Area of Science:

  • Cardiology
  • Endocrinology
  • Metabolic Diseases

Background:

  • Diabetes mellitus is a major risk factor for heart failure (HF) development.
  • Diabetic patients are at increased risk for HF, classified as Stage A by the American Societies of Cardiology.
  • Key contributors to HF in diabetes include coronary artery disease, hypertension, and diabetic cardiomyopathy.

Purpose of the Study:

  • To outline the etiological factors, diagnostic approaches, and therapeutic strategies for heart failure in diabetic patients.
  • To emphasize the importance of managing cardiovascular risk factors in diabetes to prevent HF.
  • To clarify medication choices for diabetic patients with or at risk of HF.

Main Methods:

  • Review of etiological factors: coronary artery disease, systemic hypertension, diabetic cardiomyopathy, renal insufficiency, and obesity.

Related Experiment Videos

  • Diagnostic assessment mirroring non-diabetic subjects: clinical evaluation, echocardiography, and B-type natriuretic peptide levels.
  • Therapeutic strategies including non-pharmacological measures, standard HF pharmacotherapy (e.g., beta-blockers), and careful selection of antihyperglycemic agents.

    • Main Results:

    • Diabetes is a significant risk factor for heart failure.
    • Diagnosis and treatment of HF in diabetes follow established guidelines, with specific considerations for antihyperglycemic agents.
    • Effective management includes blood pressure and lipid control, ACE inhibitors for at-risk individuals, and improved glycemic control.

    Conclusions:

    • Diabetic patients require vigilant monitoring for heart failure.
    • Standard heart failure medications, including beta-blockers, are safe and beneficial.
    • Avoiding specific antihyperglycemic agents (biguanides, thiazolidinediones) is crucial in heart failure management, with exceptions for pioglitazone in early stages (NYHA I-II).